focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBowleven Share News (BLVN)

Share Price Information for Bowleven (BLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
BLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bowleven Notes Cameroon Approval For New Etinde Application

Mon, 25th Jan 2021 11:45

(Alliance News) - Bowleven PLC on Monday said formal approval to apply for a new Etinde licence exploitation agreement had been granted by the Cameroon government.

Shares in Bowleven were up 27% at 5.16 pence in London just before midday.

Oil and gas exploration firm Bowleven has a 25% non-operated interest in the offshore Cameroon shallow water Etinde permit, formerly known as block MLHP-7. Operator New Age Ltd holds a 37.5% stake and PJSC Lukoil Oil Co the remaining 37.5%.

New Age Ltd now has obtained formal approval to apply for a new Etinde exploitation agreement, replacing the existing agreement which came into force by presidential decree in January 2015.

This agreement was reached after talks with Societe Nationale des Hydrocarbures, which is Cameroon's national oil and gas company and was also the government's representative in talks.

The new agreement would be for hydrocarbon production, including delivering gas to thermal power plants or other projects confirmed by the state.

Bowleven Chief Executive Eli Chahin said: "This is very positive news for the Etinde development, as it essentially eliminates the possibility of the government of Cameroon removing the Etinde licence from the [joint venture] partners, following the end of the initial six year development implementation period in January 2021.

"The JV partners continue to make good progress towards achieving a final investment decision on the licence in 2021 and I look forward to keeping all our stakeholders updated on developments over the coming months."

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Jun 2014 10:46

DIRECTOR DEALINGS: Bowleven CEO Buys 50,000 Shares

Read more
27 Jun 2014 09:19

Bowleven farms out 20% of Bomono project to AFC

AIM-listed oil and gas exploration group Bowleven has entered into a farm-out drill-to-earn arrangement with Africa Fortesa Corp (AFC). AFC will earn a 20% interest in the group's Bomono Permit in return for drilling two exploration wells. Based on the terms of the arrangement, the cost of the two

Read more
27 Jun 2014 08:25

Bowleven Farms Out 20% Of Bomono Permit To Africa Fortesa Corp

Read more
27 Jun 2014 07:28

UK MORNING BRIEFING: Imagination Technologies Hit By Intel Share Sale

Read more
24 Jun 2014 12:26

Bowleven derisks with Etinde farmout, ending Petrofac deal

Africa-focused oil and gas explorer Bowleven has achieved its much anticipated farm-out agreement on its Etinde Permit offshore Cameroon. The AIM-listed company has farmed out two thirds of its 75% stake in Etinde to Russia's Lukoil and private equity-backed explorer NewAge for $250m. In return fo

Read more
24 Jun 2014 11:07

UK MIDDAY BRIEFING: BG Group Fires Up Curtis Island Processing Units

Read more
24 Jun 2014 10:34

UK WINNERS & LOSERS: Imagination Tech Jumps As Licensing Revenue Flows

Read more
24 Jun 2014 07:46

Bowleven Sells 50% Stake In Etinde Permit For USD250 Million

Read more
24 Jun 2014 07:29

UK MORNING BRIEFING: London Shares Firm Ahead Of Carney Testimony

Read more
3 Jun 2014 12:46

Broker tips: Shire, Foxtons, Tate & Lyle, Bowleven

UBS has hiked its target price for Shire by nearly a tenth, saying that the rumoured acquisition of Nasdaq-listed NPS Pharmaceuticals would "make sense" for the Dublin-based biopharmaceutical group. The bank kept a 'neutral' stance on the shares, but lifted its target from 3,150p to 3,450p. UBS sai

Read more
3 Jun 2014 11:41

UK MIDDAY BRIEFING: Wolseley's US Growth Offsets Currency Hit

LONDON (Alliance News) - Wolseley is the biggest gainer on the FTSE 100 Tuesday after the plumbing and heating products distributor reported higher trading profit for its fiscal third quarter, driven by strong growth in the US and Nordic countries.

However, adverse

Read more
3 Jun 2014 10:30

UK WINNERS & LOSERS: Wolseley Stands Out From Negative FTSE 100

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.
-------
FTSE 100 - WINNERS
-------
Wolseley, up 2.7%. The plumbing and heating products distributor is one of ju

Read more
3 Jun 2014 09:36

Bowleven development receives Cameroon state approval

Africa-focused oil and gas group Bowleven saw its shares race ahead on Tuesday after the receiving state support for the next step of its Etinde project offshore Cameroon. Following meetings last month, a formal resolution confirming Cameroon's approval of the Etinde Exploitation Authorisation Appl

Read more
3 Jun 2014 09:35

Westhouse says market underestimating Etinde potential at Bowleven

Westhouse Securities has maintained its 'buy' recommendation for Africa-focused oil and gas group Bowleven after the company achieved a "key hurdle" in progressing its Etinde gas and condensate project offshore Cameroon. Following meetings last month, a formal resolution confirming Cameroon's appro

Read more
3 Jun 2014 07:31

Bowleven Gets Cameroon Government Approval For Etinde Application

LONDON (Alliance News) - Bowleven PLC Tuesday said a formal resolution confirming the Cameroon government's support for its Etinde Exploitation Authorisation application has been signed. The Africa focused oil and gas exploration company said the resolution was signed following a meeting on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.